Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MERGERS AND ACQUISITIONS
Vertex Undergoes FTC Scrubbing for Deal on CF Treatment
By William McConnell
May 22, 2017 6:29 PM EDT
PRESS RELEASES
Concert Pharmaceuticals To Present At Upcoming Investor Conferences
By Business Wire
Nov 9, 2020 7:00 AM EST
PRESS RELEASES
Concert Pharmaceuticals Initiates THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 For Alopecia Areata
By Business Wire
Nov 3, 2020 7:00 AM EST
PRESS RELEASES
Concert Pharmaceuticals Presents CTP-543 Data From Long-Term Extension Study In Alopecia Areata During Late-Breaking Session At EADV Congress
By Business Wire
Oct 29, 2020 10:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals To Report Third Quarter 2020 Financial Results On November 5, 2020
By Business Wire
Oct 29, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals Announces Publication On Alopecia Areata Burden Of Disease In Journal Of Investigative Dermatology
By Business Wire
Oct 22, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals Announces CTP-543 Alopecia Areata Data Selected For Late-Breaker Oral Presentation At 2020 EADV Virtual Congress
By Business Wire
Oct 13, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals Completes Enrollment In CTP-692 Phase 2 Trial In Patients With Schizophrenia
By Business Wire
Sep 29, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals To Present At Upcoming Investor Conferences
By Business Wire
Sep 8, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals To Present At The JMP Securities CNS Forum
By Business Wire
Aug 18, 2020 6:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 6, 2020
By Business Wire
Jul 30, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals Releases Additional Data From Phase 2 Clinical Trial Of CTP-543 In Alopecia Areata
By Business Wire
Jun 12, 2020 4:01 PM EDT
PRESS RELEASES
Concert Pharmaceuticals To Webcast Fireside Chat At Jefferies Virtual Global Healthcare Conference
By Business Wire
May 26, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals To Webcast Presentation At UBS Virtual Healthcare Conference
By Business Wire
May 12, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals To Report First Quarter 2020 Financial Results On April 30, 2020
By Business Wire
Apr 23, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals Announces Plans For CTP-543 Phase 3 Trials In Alopecia Areata
By Business Wire
Apr 1, 2020 7:00 AM EDT
PRESS RELEASES
Concert Pharmaceuticals Selected For Late-Breaking Oral Presentation Of CTP-543 Phase 2 Data In Alopecia Areata At The 2020 American Academy Of Dermatology Annual Meeting
By Business Wire
Feb 24, 2020 7:00 AM EST
PRESS RELEASES
Concert Pharmaceuticals To Report Full Year 2019 Results On February 27, 2020
By Business Wire
Feb 20, 2020 7:00 AM EST
PRESS RELEASES
Concert Pharmaceuticals Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares
By Business Wire
Jan 30, 2020 4:01 PM EST
PRESS RELEASES
Concert Pharmaceuticals Announces Pricing Of Public Offering
By Business Wire
Jan 28, 2020 9:00 AM EST
PRESS RELEASES
Concert Pharmaceuticals Announces Proposed Public Offering Of Common Stock
By Business Wire
Jan 27, 2020 4:02 PM EST
PRESS RELEASES
Concert Pharmaceuticals Announces Federal Circuit Granted Its Motion To Vacate And Remand PTAB Decision Involving CTP-543
By Business Wire
Jan 27, 2020 4:01 PM EST
PRESS RELEASES
Concert Pharmaceuticals Announces Notice Of Allowance For U.S. Patent Application Related To CTP-543, Lead Candidate For Treatment Of Alopecia Areata
By Business Wire
Jan 22, 2020 8:40 AM EST
MERGERS AND ACQUISITIONS
Vertex Undergoes FTC Scrubbing for Deal on CF Treatment
By William McConnell
May 22, 2017 6:29 PM EDT
STOCKS
Hold on Concert's Hair Loss Trials Pushes Shares Down 10%
By William McConnell
May 17, 2017 9:52 AM EDT
